There's a very simple reason why EDTA chelation therapy is not more widely accepted for treatment of atherosclerotic coronary artery disease.
Multiple randomized clinical trials have failed to show a benefit greater than placebo in either symptoms or arterial occlusion as measured by angiography.
It's that simple.
-- Orac |"A statement of fact cannot be insolent." | |"If you cannot listen to the answers, why do you | inconvenience me with questions?"
On Mon, 10 May 2004 00:09:13 GMT, Orac <[email hidden]> wrote:
Quoted message said:
Quoted message said:
There's a very simple reason why EDTA chelation therapy is not more widely accepted for treatment of atherosclerotic coronary artery disease.
Multiple randomized clinical trials have failed to show a benefit greater than placebo in either symptoms or arterial occlusion as measured by angiography.
It's that simple.
Nope ... far from it.
Really? Do tell. What evidence from randomized double-blind trials is there that chelation therapy improves symptoms of atherosclerotic cornary artery or peripheral artery disease or that it decreases plaque as measured by angiography?
-- Orac |"A statement of fact cannot be insolent." | |"If you cannot listen to the answers, why do you | inconvenience me with questions?"